Drug Approval | April 21, 2022
Boehringer Ingelheim launches RenuTend to heal ligament injuries in horses
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Targeted action improves quality of healing of tendon and suspensory ligament injuries in horses
Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes
Vacuum-Assisted Breast Biopsy (VABB) is an innovative and more effective alternative to the traditional method where benign lumps are removed surgically, leaving scars and causing distress
New kit enhances menu of FFPE solutions and allows oncology researchers to extract higher yields of concentrated DNA compared to traditional techniques
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
India-Sweden Healthcare Innovation Centre in collaboration with AIIMS Jodhpur and AstraZeneca India launches an e-learning Upskilling Program in Diabetes Management for nurses
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Subscribe To Our Newsletter & Stay Updated
